Drugs Made In America Acquisition II LLC
CIK 2088432 · View on SEC EDGAR ↗
First SEC filing: Sept. 25, 2025 · Latest: Oct. 2, 2025
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 26, 2025 | DMIIU | P | 700,000 | — | — | 700,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Sept. 26, 2025 | DMIIU | S | 7,966,667 | — | — | 6,708,333 Direct | -54.29% | Disposed | (price as of 2026-08-21) |
| Sept. 26, 2025 | DMIIU | P | 700,000 | — | — | 15,075,000 Direct | +4.87% | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 26, 2025 | DMIIU | Rights to receive ordinary shares | Ordinary shares (700,000) | — | — | 700,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 25, 2025 | DMIIU | Ordinary Shares | 14,375,000 | Direct |